SITE012-0093

SITE012 (BRA) › SITE012-0093

SITE012-0093

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE012 (BRA) · Dr. Kowalski
consented 2025-12-17

enrolled

AEs

4

Serious

0

Dropout signal

–

Adverse events

4

Grade 2 Vomiting — outcome: RECOVERED/RESOLVED; onset 2023-01-28 (study day 213); relationship: not assessed

moderate assessed

Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2023-01-13 (study day 198); relationship: not assessed

mild assessed

Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-11-23 (study day 147); relationship: NOT RELATED

mild assessed

Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-07-07 (study day 8); relationship: not assessed

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.